Evidentic

[Evidentic @Evidentic_]

At Evidentic we source therapeutic molecules as aliquots from commercial drugs. Our latest addition is Trastuzumab Deruxtecan (https://t.co/wKcDHAC1T7). To find more please visit our website at https://t.co/YJYjvQ3fgt.

#drugdiscoveryproduct #drugdevelopment #biologics

[Evidentic @Evidentic_]

You can now order biosimilar Etanercept (Benepali®) for your early drug development projects at https://t.co/JKDLa1oEfO.

#drugdevelopment #drugdevelopmentproduct #sourcingspecialist #therapeuticmolecules #fusionprotein

[Evidentic @Evidentic_]

With Evidentic, the procurement of therapeutic molecules is easy like 1, 2, 3: First, you let us know what you need, then we send you an offer and finally send it to you. Our last addition is Sacituzumab Govitecan (from the original drug Trodelvy)® https://t.co/5smoJwNeMg.

[Evidentic @Evidentic_]

@hhlleipzig I have contacted my Russian clients to let them know that West knows it not the aggression of the Russian nation but only of the political elite. #StopWar #StopPutin

[Evidentic @Evidentic_]

Difficulty in sourcing clinical-grade molecules for your projects? Not anymore. Just ask us for the molecule that you need and I will procure it for you.

[Evidentic @Evidentic_]

Having access to different batches of the same API at the same time is a time consuming and costly task, and sometimes even impossible. At #evidentic, we stock drug aliquots from therapeutic molecules, readily available to be used on your research projects.

[Evidentic @Evidentic_]

Regdanvimab, a mAb that targets SARS-CoV-2 Spike protein, is now included in our on-demand portfolio. Please check all about this therapeutic protein at https://t.co/BItawyGwfu.

#covid #mabs #cgm4rnd

[Evidentic @Evidentic_]

Early drug developers, and more specifically biosimilar developers, use reference standards to develop biosimilar drugs. Read more about Reference Standards for Biosimilar Development https://t.co/ZCL2J9anLW

#drugdevelopement #referencestandards #drugdesign

[Evidentic @Evidentic_]

Our aliquots are readily available, cost-effective and in small quantities to be used on your research projects. Drop us an email at [email protected] and let us know your requirements.

#mabs #therapeuticmolecules #universidadedecoimbra #speedingupearlydrugdevelopment

[Evidentic @Evidentic_]

The #bispecifc antibody Amivantamab has just been approved by EMA, after showing great results to treat patients with Non-Small-Cell Lung Carcinoma (NSCLC).
Please send us an email to [email protected] to receive a quote today.

[Evidentic @Evidentic_]

Evidentic is your sourcing specialist of EU licenced clinical-grade molecules. We have expanded our portfolio with a brand new molecule: Albutrepenonacog Alfa (clotting factor IX). Check this and other in-stock products at https://t.co/eeverXKNOp.

[Evidentic @Evidentic_]

Sourcing clinical-grade molecules made easy. From sourcing medicines to delivering the aliquots to you. Check our portfolio at https://t.co/24w4DKOhxV

[Evidentic @Evidentic_]

Orphan drugs are designed to treat disease conditions that are rarely observed in people. Read more about the regulations and challenges in the development process of these drugs. https://t.co/ZNi3kOAGpb

#orphandrugs #newdrugs #makingabetterworld #cgm4rnd

[Evidentic @Evidentic_]

We want to help you to speed up your drug development projects. Check how we have helped Synermore Biologics.
We are here to help you reach your goals!

#drugdevelopment #reachyourgoals #cgm4rnd

[Evidentic @Evidentic_]

The market of Monoclonal Antibodies is expected to reach $329.6 Billion by 2030, with an annual growth of 10.9% over 2020-2030 https://t.co/HYjUjjnD9l.
If you require therapeutic molecules for your early drug development projects, go to https://t.co/8SWnDxkgIm.

[Evidentic @Evidentic_]

The current spectrum of therapeutic antibody formats can be divided into naturally occurring antibody formats and antibody fragments. Read more at https://t.co/eGSwqD8Mah

[Evidentic @Evidentic_]

Learn from our customers what they have to say about how the aliquots helped them to reach their goals. For more testimonials visit our website under case studies https://t.co/yYlx36xsuj.

#drugdevelopment #cgm4rnd #researchforabetterworld #testimonial

[Evidentic @Evidentic_]

At Evidentic, we are always expanding our portfolio to fulfil the needs of your research projects. Natalizumab (https://t.co/77n1mpVn33) is our newest product in stock. We look forward to helping you reach your goals!

#cgm4rnd #mabs #natalizumab #researchforabetterworld

[Evidentic @Evidentic_]

Evidentic launched last year a scholarship, to award young scientists for their work. Check Ashley' results at https://t.co/vIUEAWP2Su.

[Evidentic @Evidentic_]

Today we want to share with you how Dr. Stephan Schultz, from UGA Biopharma, has experience using Evidentic's drug aliquots. We can also help you to reach your goals.